IP Library › Granted Patent US 12,168,211
Granted Patent B2
US 12,168,211 · App. 17/745,128 · Granted Dec 17, 2024

Reusable initiators for synthesizing nucleic acids

Inventors: J. William Efcavitch (San Carlos, CA); Matthew T. Holden (San Diego, CA)
Assignee: Molecular Assemblies, Inc.
B01J19/0046C12N9/1264C12P19/34C12Q1/6806C12Q1/6811C12Q1/6837B01J2219/00596B01J2219/00722C12Q2525/101C12Q2525/117C12Q2525/186C12Y207/07019C12Y207/07031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,168,211
App. No.
17/745,128
Granted
Dec 17, 2024
Kind
B2
Abstract

The invention provides improved methods for synthesizing polynucleotides, such as DNA and RNA, using renewable initiators coupled to a solid support. Using the methods of the invention, specific sequences of polynucleotides can be synthesized de novo, base by base, in an aqueous environment, without the use of a nucleic acid template.

Claims (21)

1. A method for synthesizing oligonucleotides on a reusable solid support, the method comprising:

exposing a nucleic acid initiator attached to a solid support to nucleotide analogs in the presence of a polymerase to create a first oligonucleotide, wherein the nucleic acid initiator comprises a sequence-specific cleavage element;

contacting the nucleic acid initiator with a releasing agent to cleave the sequence-specific cleavage element and release the first oligonucleotide from the nucleic acid initiator;

dephosphorylating a 3′-end of the solid support-attached nucleic acid initiator; and

enzymatically renewing the sequence-specific cleavage element.

2. The method of claim 1 wherein the nucleic acid initiator comprises a 5′-amine, 5′-hydroxyl, 5′-phosphate, 5′-sulfhydryl, or 5′-benzaldehyde group attached to the solid support comprising formyl, chloromethyl, epoxide, amine, thiol, alkene, or terminal C-F bonds.

3. The method of claim 1 wherein the nucleic acid initiator is irreversibly attached to the solid support.

4. The method of claim 1 wherein the sequence-specific cleavage element is incorporated into the nucleic acid initiator after a 5′ end of the nucleic acid initiator has been irreversibly coupled to the solid support.

5. The method of claim 4 wherein the sequence-specific cleavage element is incorporated enzymatically.

6. The method of claim 1 wherein the sequence-specific cleavage element comprises a poly-U tract.

7. The method of claim 1 wherein the nucleic acid initiator comprises an index element, the method further comprising:

extending a 3′ end of the nucleic acid initiator with complementary nucleotide analogs to a 3′ sequence of the nucleic acid initiator to synthesize the first oligonucleotide under to permit hairpin formation;

extending the first oligonucleotide after hairpin formation using the index element as a template.

8. The method of claim 7 wherein the 3′ sequence of the nucleic acid initiator is complimentary to the sequence-specific cleavage element.

9. The method of claim 7 , further comprising incorporating a homopolymer tract into the first oligonucleotide to create a single stranded 3′ end thereof subsequent to the hairpin.

10. The method of claim 1 , further comprising:

before contacting the nucleic acid initiator with a releasing agent, incorporating a second sequence-specific cleavage element on a 3′ end of the first oligonucleotide to create a second nucleic acid initiator and exposing the second nucleic acid initiator, attached to the first oligonucleotide, to nucleotide analogs in the presence of a polymerase to create a second oligonucleotide,

wherein contacting the nucleic acid initiator and the second nucleic acid initiator with the releasing agent cleaves the sequence-specific cleavage element and the second sequence-specific cleavage element and release the first oligonucleotide and the second oligonucleotide from the nucleic acid initiator and the second nucleic acid initiator.

11. The method of claim 1 , wherein the polymerase is a nucleotidyl transferase or a modified nucleotidyl transferase.

12. The method of claim 1 , wherein the polymerase is terminal deoxynucleotidyl transferase (TdT) or a modified TdT.

13. The method of claim 1 , wherein the nucleotide analogs have an unmodified 3′-OH and a cleavable terminating group, and wherein the cleavable terminating group blocks subsequent nucleotidyl transferase activity but results in a nucleotide substrate for nucleotidyl transferase upon cleavage of the terminating group.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2023
From: EFCAVITCH, J. WILLIAM; HOLDEN, MATTHEW T.
To: MOLECULAR ASSEMBLIES, INC.
Reel/Frame 065539/0143 →
Continuity (9)
Continuation 16261229 · Jan 29, 2019
Continuation In Part 14829269 · Aug 18, 2015
Continuation In Part 14459014 · Aug 13, 2014
Continuation In Part 14056687 · Oct 17, 2013
Provisional Application 62069067 · Oct 27, 2014
Provisional Application 62038604 · Aug 18, 2014
Provisional Application 61891162 · Oct 15, 2013
Provisional Application 61807327 · Apr 2, 2013
Related Publication 20230103381A1 · Apr 6, 2023